Chi X. Shao
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
68Ga-FAPI PET/CT features of thoracic sarcoidosis: a prospective observational study.
Journal: BMC pulmonary medicine
Published: March 30, 2026
Copanlisib ameliorates pulmonary fibrosis by modulating cellular autophagy through PI3K/Akt/mTORC1 pathway.
Journal: Journal of thoracic disease
Published: January 13, 2026
Repurposing the MEK inhibitor binimetinib as a dual anti-inflammatory and antifibrotic agent in pulmonary fibrosis.
Journal: Journal of thoracic disease
Published: December 21, 2025
Efficacy of antifibrotic treatment for ANCA-positive fibrosing interstitial lung disease: a retrospective case‒control study.
Journal: BMC pulmonary medicine
Published: October 12, 2025
Nerandomilast attenuates Pantoea agglomerans-induced hypersensitivity pneumonitis by regulating M1 macrophage polarization and fibroblast activation.
Journal: Respiratory research
Published: October 07, 2025
Clinical analysis of eight patients with lung biopsy-proven pulmonary intravascular large B-cell lymphoma in a single center.
Journal: Hematology (Amsterdam, Netherlands)
Published: October 03, 2025
A case report of idiopathic pulmonary fibrosis concurrent with EGFR 19 deletion lung adenocarcinoma.
A case report of idiopathic pulmonary fibrosis concurrent with EGFR 19 deletion lung adenocarcinoma.
Journal: Translational cancer research
Published: October 01, 2025
Crizotinib attenuates bleomycin-induced pulmonary fibrosis via regulating fibroblast activation.
Journal: Journal of thoracic disease
Published: August 22, 2025
Clinical characteristics and prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: a retrospective study.
Journal: Clinical and experimental rheumatology
Published: June 06, 2025
Last Updated: 09/26/2026